共 50 条
- [5] SPIRIT II clinical study:: A clinical evaluation of the XIENCE™ v Everolimus Eluting Coronary Stent System in the treatment of patients with de novo native coronary artery lesions AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 147M - 147M
- [6] 3-Year Clinical Follow-Up of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients With De Novo Coronary Artery Lesions The SPIRIT II Trial (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions) JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (12) : 1190 - 1198
- [9] Clinical Follow-Up 3 Years After Everolimus- and Paclitaxel-Eluting Stents A Pooled Analysis From the SPIRIT II (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions) and SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) Randomized Trials JACC-CARDIOVASCULAR INTERVENTIONS, 2010, 3 (12) : 1220 - 1228